eamdacademy.org-LmlF-1793361508-b722721918 1793361508 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2025 4 1 Claire Dupont Julien Martin 2025 10.68159/b722721918 https://eamdacademy.org/pub/journal/3/article/b722721918 Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-77. 10.1038/s41573-019-0024-5 Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discov Today. 2019;24(3):773-80. 10.1016/j.drudis.2018.11.014 Kolluri S, Lin J, Liu R, Zhang Y, Zhang W. Machine learning and artificial intelligence in pharmaceutical research and development: a review. AAPS J. 2022;24(1):19. 10.1208/s12248-021-00644-3 Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Machine learning directed drug formulation development. Adv Drug Deliv Rev. 2021;175:113806. 10.1016/j.addr.2021.113806 Bao Z, Bufton JC, Hickman RJ, Aspuru-Guzik A, Bannigan P, Allen C. Revolutionizing drug formulation development: the increasing impact of machine learning. Adv Drug Deliv Rev. 2023;202:115108. 10.1016/j.addr.2023.115108 Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. 10.3390/pharmaceutics15071916 Arden NS, Fisher AC, Tyner K, Yu LX, Lee SL, Kopcha M. Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future. Int J Pharm. 2021;602:120554. 10.1016/j.ijpharm.2021.120554 Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. Eur J Pharm Sci. 2024;203:106938. 10.1016/j.ejps.2024.106938 Jiménez-Luna J, Grisoni F, Schneider G. Drug discovery with explainable artificial intelligence. Nat Mach Intell. 2020;2(10):573-84. 10.1038/s42256-020-00236-4 Ekins S, Puhl AC, Zorn KM, Lane TR, Russo DP, Klein JJ, et al. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019;18(5):435-41. 10.1038/s41563-019-0338-z Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell. 2019;1(5):206-15. 10.1038/s42256-019-0048-x Shortliffe EH, Sepúlveda MJ. Clinical decision support in the era of artificial intelligence. JAMA. 2018;320(21):2199-200. 10.1001/jama.2018.17163 Binns R. Algorithmic accountability and public reason. Philos Technol. 2018;31(4):543-56. 10.1007/s13347-017-0263-5 Kroll JA. The fallacy of inscrutability. Philos Trans A Math Phys Eng Sci. 2018;376(2133):20180084. 10.1098/rsta.2018.0084 Arrieta AB, Díaz-Rodríguez N, Del Ser J, Bennetot A, Tabik S, Barbado A, et al. Explainable artificial intelligence (XAI): concepts, taxonomies, opportunities and challenges toward responsible AI. Inf Fusion. 2020;58:82-115. 10.1016/j.inffus.2019.12.012 Schneider P, Walters WP, Plowright AT, Sieroka N, Listgarten J, Goodnow RA Jr, et al. Rethinking drug design in the artificial intelligence era. Nat Rev Drug Discov. 2020;19(5):353-64. 10.1038/s41573-019-0050-3 Morley J, Floridi L, Kinsey L, Elhalal A. From what to how: an initial review of publicly available AI ethics tools, methods and research to translate principles into practices. In: Ethics, governance, and policies in artificial intelligence. Cham: Springer; 2021. p.153-83. 10.1007/978-3-030-81907-1_9 Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: a roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337-40. 10.1038/s41591-019-0548-6 Nagendran M, Chen Y, Lovejoy CA, Gordon AC, Komorowski M, Harvey H, et al. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ. 2020;368:m689. 10.1136/bmj.m689 Coeckelbergh M. Artificial intelligence, responsibility attribution, and a relational justification of explainability. Sci Eng Ethics. 2020;26(4):2051-68. 10.1007/s11948-019-00146-8 Amann J, Blasimme A, Vayena E, Frey D, Madai VI, Precise4Q Consortium. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak. 2020;20(1):310. 10.1186/s12911-020-01332-8 Mirakhori F, Niazi SK. Harnessing the AI/ML in drug and biological products discovery and development: the regulatory perspective. Pharmaceuticals (Basel). 2025;18(1):47. 10.3390/ph18010047